A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
David Lebwohl(Intellia Therapeutics (United States)), Neal Rosen(Memorial Sloan Kettering Cancer Center), Patrick I. Borgen(Maimonides Medical Center), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Merna N. Timaul(Memorial Sloan Kettering Cancer Center), Robin C. Muise‐Helmericks(Medical University of South Carolina), S Serve, R Bol
PubMed
July 1, 1994
Cited by 84
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
|Cancer Research|2006|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k